首页> 美国卫生研究院文献>Critical Care >Clinical review: Volume of fluid resuscitation and the incidence of acute kidney injury - a systematic review
【2h】

Clinical review: Volume of fluid resuscitation and the incidence of acute kidney injury - a systematic review

机译:临床评价:液体复苏量和急性肾损伤的发生率-系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Intravenous fluids are widely administered to maintain renal perfusion and prevent acute kidney injury (AKI). However, fluid overload is of concern during AKI. Using the Pubmed database (up to October 2011) we identified all randomised controlled studies of goal-directed therapy (GDT)-based fluid resuscitation (FR) reporting renal outcomes and documenting fluid given during perioperative care. In 24 perioperative studies, GDT was associated with decreased risk of postoperative AKI (odds ratio (OR) = 0.59, 95% confidence interval (CI) = 0.39 to 0.89) but additional fluid given was limited (median: 555 ml). Moreover, the decrease in AKI was greatest (OR = 0.47, 95% CI = 0.29 to 0.76) in the 10 studies where FR was the same between GDT and control groups. Inotropic drug use in GDT patients was associated with decreased AKI (OR = 0.52, 95% CI = 0.34 to 0.80, P = 0.003), whereas studies not involving inotropic drugs found no effect (OR = 0.75, 95% CI = 0.37 to 1.53, P = 0.43). The greatest protection from AKI occurred in patients with no difference in total fluid delivery and use of inotropes (OR = 0.46, 95% CI = 0.27 to 0.76, P = 0.0036). GDT-based FR may decrease AKI in surgical patients; however, this effect requires little overall FR and appears most effective when supported by inotropic drugs.
机译:广泛使用静脉输液以维持肾脏灌注并预防急性肾损伤(AKI)。但是,在AKI期间,应注意流体过载。使用Pubmed数据库(截至2011年10月),我们确定了基于目标导向疗法(GDT)的液体复苏(FR)的所有随机对照研究,这些研究报告了肾结局并记录了围手术期护理期间给予的液体。在24项围手术期研究中,GDT与术后AKI风险降低相关(比值比(OR)= 0.59,95%置信区间(CI)= 0.39至0.89),但补充的液体有限(中位数:555毫升)。此外,在GDT与对照组之间FR相同的10项研究中,AKI的下降最大(OR = 0.47,95%CI = 0.29至0.76)。在GDT患者中使用正性肌力药物与AKI降低相关(OR = 0.52,95%CI = 0.34至0.80,P = 0.003),而不涉及正性肌力药物的研究则没有效果(OR = 0.75,95%CI = 0.37至1.53 ,P = 0.43)。对AKI的最大保护发生在总输液量和使用正性肌力药物无差异的患者中(OR = 0.46,95%CI = 0.27至0.76,P = 0.0036)。基于GDT的FR可能会降低手术患者的AKI;但是,这种作用所需的总FR很少,在正性肌力药物支持下似乎最有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号